Weill Cornell team identifies new cancer stem cell driving metastatic tumors
CD133- cells can initiate metastatic disease, could redirect cancer research
NEW YORK (May 27, 2008) — The molecular profile of cancer stem cells that initiate metastatic colon tumors is significantly different from those responsible for primary tumors, according to new research from a team at Weill Cornell Medical College.
Share This
Previous Stories
- Researchers find gene location that gives rise to neuroblastoma, an aggressive childhood cancer
- Mammograms benefit women up to the age of 75 and 3-yearly screening intervals are best
- Inherited cancer mutation is widespread in America
- Human breast tumors’ ‘microenvironment’ primes them for metastasis
- Enzyme complex could be key to new cancer treatments
- High-intensity ultrasound may launch attack on cancer, wherever it lurks
- Defects in critical gene lead to accelerated lung tumor growth
- Study could impact noninvasive treatment of cancer tumors
- Simple steps make breast cancer survivors eager to exercise, study shows
- Can a Mediterranean diet help prevent colon cancer?
- Deakin University research finds rogue cells that could cause spread of breast cancer
- Migration alert — How tumor cells home in on the lymphatic system
- Study suggests newer breast cancer drug may protect heart
- Alzheimer’s enzyme acts as a tumor suppressor
- Rochester spreads knowledge of cancer-related fatigue
- Study shows big power of small RNAs, not just proteins, in halting cancer
- University of Pittsburgh scientists find new contributor to aggressive cancers
- Finding protection from tumor growth in unexpected places
- Transplantation does not benefit patients with refractory myeloma
- Scientists develop new drugs to fight colon and breast cancer more effectively
- Common cancer gene sends death order to tiny killer
- Researchers discover inherited mutation for leukemia
- First confirmed common genetic risk factors for breast cancer
- Intake of vitamin D and calcium associated with lower risk of breast cancer before menopause
- New mouse model closely mimics human cancers
- Possible new breast cancer gene
- Nanocomposite labeled cancer cells can be targeted and destroyed using lasers
- Computer-aided detection with computed radiography effective in detecting breast cancer
- Decrease in breast cancer rates likely reflect HRT reduction and saturation of mammography
- pHLIP, a novel technology to locate and treat tumors
- Researchers urge caution in using ESAs for cancer-related anemia
- Combination treatment stymies breast cancer growth
- Unstable leukemia stem cells may predispose patients to drug resistance
- UCSF brain tumor vaccine trial shows promising results
- Treatment-induced growth factor causes cancer progression
- Northwestern chemists develop new method for synthesizing anti-cancer flavonoids
- Cure for cancer one step closer
- Gender linked to development of skin cancer
- Study identifies multiple genetic risk factors for prostate cancer
- A sweet step toward new cancer therapies
- Protein averts cell suicide but might contribute to cancer
- Cryoablation — A new treatment option for some kidney tumor patients
- Natural mechanism for immune suppression paves way for cancer trials
- Immune response to cancer stem cells may dictate cancer’s course
- Targeting tumors the natural way
- Blueberries contain chemical that may help prevent colon cancer
- Study suggests test for p53 is needed to prescreen patients for blood cancer drugs
- Personalized diets may offer relief to advanced cancer patients
- Queen’s studies find new links between wine, fermented foods and cancer
